Hot Topics in Pharmacy: MCM 22 Highlights: NIOSH List of Hazardous Drugs in Healthcare Settings

In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.